Mathew Leigh

Title: Mathew Leigh - Innovator in Pharmaceutical Composition

Introduction

Mathew Leigh is a notable inventor based in Muttenz, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical applications. His work focuses on enhancing the delivery and efficacy of essential compounds in therapeutic settings.

Latest Patents

Mathew Leigh holds a patent for a pharmaceutical composition that includes a DHA ester to be administered parenterally. This invention relates to a formulation that comprises submicronic ester particles of docosahexaenoic acid, which are dispersed in an aqueous phase using a mixture of at least two surfactants. These surfactants include at least one polyoxyethylene fatty acid ester and at least one phospholipid derivative. The patent also outlines the method for preparing this pharmaceutical composition, showcasing his innovative approach to drug delivery.

Career Highlights

Throughout his career, Mathew has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Pierre Fabre Medicament and Medlite A/S, where he has contributed to various projects aimed at improving health outcomes through advanced pharmaceutical solutions.

Collaborations

Mathew has collaborated with esteemed professionals in his field, including Elie Leverd and Peter Van Hoogevest. These partnerships have allowed him to enhance his research and development efforts, leading to impactful innovations in pharmaceutical compositions.

Conclusion

Mathew Leigh's contributions to the pharmaceutical industry, particularly through his patent on DHA ester compositions, highlight his role as an innovator. His work continues to influence the development of effective medical treatments, showcasing the importance of innovation in healthcare.